
Canada’s competition bureau said on Friday that its decision to start litigation to block a C$20 billion ($15.5 billion) bid by Rogers Communications for Shaw Communications does not mean a settlement cannot be reached.
The Canadian antitrust agency this week rejected the proposed deal, saying it would undermine competition in a country that has some of the world’s steepest wireless rates.
It also dismissed a proposed full divestiture of Calgary-based Shaw’s wireless business, Freedom Mobile, saying this was insufficient to address competition concerns.
A Competition Bureau spokesperson said in a statement sent to Reuters on Friday that proposed divestitures “will not eliminate the substantial lessening of competition and any remedy proposal would be assessed individually”.
But it also left the door open to a settlement. “The commencement of litigation does not prevent the parties and the Bureau from reaching an agreement to remedy the competition concerns at any time,” it added.
Some lawyers and analysts say the deal could find support from the bureau if Rogers and Shaw propose additional remedies.
Antitrust lawyers expect Rogers and Shaw to bring in buyers with a proven record in running the business, and propose a sale of some stores or spectrum to overcome the bureau’s concerns.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas